{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12"],"submitter":["Wu H"],"pubmed_abstract":["<h4>Objective</h4>Use our advanced, physiologically inspired cardiac CT perfusion (CCTP) software to distinguish ischemia due to obstructive disease vs. microvascular disease (MVD).<h4>Background</h4>Previously validated advanced CCTP methods were used. We interpreted results to identify flow-limiting stenosis [i.e., obstructive-lesion & low myocardial blood flow (MBF)] vs. microvascular disease (i.e., no-obstructive-lesion & low-MBF).<h4>Methods</h4>We retrospectively evaluated 104 patients with suspected CAD, including 18 with diabetes, who underwent CCTA + CCTP. Whole heart and territorial MBF was assessed using our automated pipeline for CCTP analysis that included beam hardening correction; temporal scan registration; automated segmentation; fast, accurate, robust MBF estimation; and visualization. Stenosis severity was scored using the CCTA coronary-artery-disease-reporting-and-data-system (CAD-RADS), with obstructive stenosis deemed as CAD-RADS ≥ 3.<h4>Results</h4>We established a threshold MBF (MBF = 200-mL/min-100 g) for normal perfusion. In patients with CAD-RADS ≥ 3 (obstructive disease), 28/37(76%) patients showed ischemia in the corresponding territory. On a per-vessel basis (<i>n</i> = 256), MBF showed a significant difference between territories with and without obstructive stenosis (165 ± 61 mL/min-100 g vs. 274 ± 62 mL/min-100 g, <i>p</i> < 0.05). A significant negative rank correlation (<i>ρ</i> = -0.53, <i>p</i> < 0.05) between territory MBF and CAD-RADS was seen. Two patients with obstructive disease had normal perfusion, suggesting collaterals and/or hemodynamically insignificant stenosis. Among diabetics, 10 of 18 (56%) demonstrated diffuse ischemia consistent with MVD. Among non-diabetics, only 6% had MVD. Sex-specific prevalence of MVD was 21%/24% (M/F).<h4>Conclusion</h4>CCTA in conjunction with a new automated quantitative CCTP approach can determine the distinction of ischemia due to obstructive lesions vs. MVD."],"journal":["Frontiers in cardiovascular medicine"],"pagination":["1621443"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12640952"],"repository":["biostudies-literature"],"pubmed_title":["Quantitative cardiac CT perfusion: physiologically-inspired model and identifying microvascular disease from discordant CTA CAD-RADS."],"pmcid":["PMC12640952"],"pubmed_authors":["Al-Kindi S","Yun CH","Rajagopalan S","Hung CL","Lee J","Huang WM","Wilson DL","Hoori A","Wu H","Song Y"],"additional_accession":[]},"is_claimable":false,"name":"Quantitative cardiac CT perfusion: physiologically-inspired model and identifying microvascular disease from discordant CTA CAD-RADS.","description":"<h4>Objective</h4>Use our advanced, physiologically inspired cardiac CT perfusion (CCTP) software to distinguish ischemia due to obstructive disease vs. microvascular disease (MVD).<h4>Background</h4>Previously validated advanced CCTP methods were used. We interpreted results to identify flow-limiting stenosis [i.e., obstructive-lesion & low myocardial blood flow (MBF)] vs. microvascular disease (i.e., no-obstructive-lesion & low-MBF).<h4>Methods</h4>We retrospectively evaluated 104 patients with suspected CAD, including 18 with diabetes, who underwent CCTA + CCTP. Whole heart and territorial MBF was assessed using our automated pipeline for CCTP analysis that included beam hardening correction; temporal scan registration; automated segmentation; fast, accurate, robust MBF estimation; and visualization. Stenosis severity was scored using the CCTA coronary-artery-disease-reporting-and-data-system (CAD-RADS), with obstructive stenosis deemed as CAD-RADS ≥ 3.<h4>Results</h4>We established a threshold MBF (MBF = 200-mL/min-100 g) for normal perfusion. In patients with CAD-RADS ≥ 3 (obstructive disease), 28/37(76%) patients showed ischemia in the corresponding territory. On a per-vessel basis (<i>n</i> = 256), MBF showed a significant difference between territories with and without obstructive stenosis (165 ± 61 mL/min-100 g vs. 274 ± 62 mL/min-100 g, <i>p</i> < 0.05). A significant negative rank correlation (<i>ρ</i> = -0.53, <i>p</i> < 0.05) between territory MBF and CAD-RADS was seen. Two patients with obstructive disease had normal perfusion, suggesting collaterals and/or hemodynamically insignificant stenosis. Among diabetics, 10 of 18 (56%) demonstrated diffuse ischemia consistent with MVD. Among non-diabetics, only 6% had MVD. Sex-specific prevalence of MVD was 21%/24% (M/F).<h4>Conclusion</h4>CCTA in conjunction with a new automated quantitative CCTP approach can determine the distinction of ischemia due to obstructive lesions vs. MVD.","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2026-06-05T19:32:47.382Z","creation":"2026-05-21T03:09:04.334Z"},"accession":"S-EPMC12640952","cross_references":{"pubmed":["41293615"],"doi":["10.3389/fcvm.2025.1621443"]}}